ArticleBMC cancer2013

Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice.

Katrina L Watson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.